Literature DB >> 10999525

Altered receptor subunit expression in rat neocortical malformations.

J J Hablitz1, R A DeFazio.   

Abstract

PURPOSE: Identification of changes in neurotransmitter function in animal models of epilepsy provides a basis for rational drug development and an understanding of the mechanisms underlying epileptogenesis. We investigated changes in the efficacy of the benzodiazepine type I agonist zolpidem and the polyamine site N-methyl-D-aspartate receptor antagonist ifenprodil in a rat model of microgyria.
METHODS: Neonatal freeze lesions were used to produce a microsulcus in the normally lissencephalic rat neocortex with anatomical similarities to human polymicrogyria. Whole-cell voltage-clamp recordings were made from visually identified layer 2/3 pyramidal cells in acutely prepared brain slices from nonlesioned and lesioned rats.
RESULTS: The effect of 20 nmol/L zolpidem on the decay time constant of inhibitory postsynaptic currents was significantly less in neurons from brain slices containing the freeze lesion. A higher concentration (100 nmol/L) of zolpidem was equally efficacious in lesioned and nonlesioned cortex. In lesioned cortex, the threshold for evoking epileptiform discharges was significantly increased in the presence of 10 micromol/L ifenprodil. This effect was significant in both intrinsic hyperexcitability and partial disinhibition with 2 micromol/L bicuculline in lesioned cortex. Ifenprodil had significantly less effect on the threshold of discharges evoked in control cortex in the partial disinhibition model.
CONCLUSIONS: The decreased sensitivity of gamma-aminobutyric acid A receptors to 20 nmol/L zolpidem in the freeze-lesion model is consistent with a delayed or arrested maturation in this animal model. These data support a delay in the developmental switch from alpha2 to alpha1 subunits in gamma-aminobutyric acid A receptors of neocortical pyramidal cells in lesioned cortex. The increased ifenprodil sensitivity of the threshold for evoking epileptiform discharges in both control and disinhibited slices containing the microsulcus is explained by a delay in the expression of the 2A (NR2A) N-methyl-D-aspartate receptor subunit. Delayed development may be a hallmark of this type of cortical dysplasia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999525     DOI: 10.1111/j.1528-1157.2000.tb01562.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  Altered intrinsic properties of neuronal subtypes in malformed epileptogenic cortex.

Authors:  Amanda L George; Kimberle M Jacobs
Journal:  Brain Res       Date:  2010-12-15       Impact factor: 3.252

2.  Early susceptibility for epileptiform activity in malformed cortex.

Authors:  Andrew Bell; Kimberle M Jacobs
Journal:  Epilepsy Res       Date:  2013-12-01       Impact factor: 3.045

3.  Glutamate biosensor imaging reveals dysregulation of glutamatergic pathways in a model of developmental cortical malformation.

Authors:  C G Dulla; H Tani; J Brill; R J Reimer; J R Huguenard
Journal:  Neurobiol Dis       Date:  2012-09-11       Impact factor: 5.996

4.  Temporal and topographic alterations in expression of the alpha3 isoform of Na+, K(+)-ATPase in the rat freeze lesion model of microgyria and epileptogenesis.

Authors:  Y Chu; I Parada; D A Prince
Journal:  Neuroscience       Date:  2009-04-09       Impact factor: 3.590

Review 5.  A review of gene expression patterns in the malformed brain.

Authors:  Mercedes F Paredes; Scott C Baraban
Journal:  Mol Neurobiol       Date:  2002-08       Impact factor: 5.590

Review 6.  Altered GABA signaling in early life epilepsies.

Authors:  Stephen W Briggs; Aristea S Galanopoulou
Journal:  Neural Plast       Date:  2011-07-31       Impact factor: 3.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.